Smith Says Roche Has `Strong Case' in Avastin Hearing
403 views · Published 28 June 2011 · 3:46 · Indexed 24 October 2026
Channel: Bloomberg Originals · 2011 · Entertainment
June 28 (Bloomberg) -- Justin Smith, an analyst at MF Global UK Ltd., discusses the outlook for the U.S. Food and Drug Administration's Oncologic Drugs advisory panel hearing on Roche Holding AG's breast-cancer drug Avastin.
The panel heard from more than 30 speakers today to open a two-day appeals hearing at the agency's headquarters in Silver Spring, Maryland. Basel, Switzerland-based Roche is contesting the FDA's Dec. 16 decision to withdraw Avastin's conditional approval in breast cancer after the agency said follow-up studies failed to show benefits to justify potential risks. Smith speaks with Betty Liu and Shannon Pettypiece on Bloomberg Television's "In the Loop." (Source: Bloomberg)
More from this channel
-
3:30
Market Close 6.4 - Bloomberg
-
0:17
Pens Tie Stanley Cup Series - Bloomberg
-
0:35
Hardware Price Too High - Activision - Bloomberg
-
0:31
FDIC Seeks Citigroup Shares-Up - WSJ - Bloomberg
-
0:44
Bank Have More Accounting Leeway - Bloomberg
-
0:32
Lakers Beat Magic 100-75 - Bloomberg
-
0:30
Johnson Wins 300th Game - Bloomberg
-
1:13
GM Expects To Sell Saturn To Penske Automotive - Bloomberg